These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 10697931

  • 1. Low-dose oral methotrexate management of patients with bilateral Ménière's disease.
    Kilpatrick JK, Sismanis A, Spencer RF, Wise CM.
    Ear Nose Throat J; 2000 Feb; 79(2):82-3, 86-8, 91-2. PubMed ID: 10697931
    [Abstract] [Full Text] [Related]

  • 2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 3. Open trial of methotrexate as treatment for autoimmune hearing loss.
    Matteson EL, Fabry DA, Facer GW, Beatty CW, Driscoll CL, Strome SE, McDonald TJ.
    Arthritis Rheum; 2001 Apr; 45(2):146-50. PubMed ID: 11324778
    [Abstract] [Full Text] [Related]

  • 4. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C, Franco-Vidal V, Bebear JP, Darrouzet V.
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [Abstract] [Full Text] [Related]

  • 5. Long-term results of low dose intramuscular streptomycin for Menière's disease.
    Shea JJ, Ge X, Orchik DJ.
    Am J Otol; 1994 Jul; 15(4):540-4. PubMed ID: 8588611
    [Abstract] [Full Text] [Related]

  • 6. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA, Couthino De Toledo H, Hinojosa-González R, Pane-Pianese C, Ríos-Castañeda LC.
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [Abstract] [Full Text] [Related]

  • 7. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E, Aidonis I, Sismanis A.
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [Abstract] [Full Text] [Related]

  • 8. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
    Akkuzu B, Ozgirgin N, Ozlüoğlu LN.
    Kulak Burun Bogaz Ihtis Derg; 2006 Apr; 16(5):193-9. PubMed ID: 17124437
    [Abstract] [Full Text] [Related]

  • 9. Alternobaric oxygen therapy in long-term treatment of Ménière's disease.
    Fattori B, De Iaco G, Nacci A, Casani A, Ursino F.
    Undersea Hyperb Med; 2002 Apr; 29(4):260-70. PubMed ID: 12797667
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Ménière's disease: an interdisciplinary review.
    Li CS, Lai JT.
    Acta Neurochir (Wien); 2008 Jul; 150(7):655-61; discussion 661. PubMed ID: 18536995
    [Abstract] [Full Text] [Related]

  • 11. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.
    Matteson EL, Choi HK, Poe DS, Wise C, Lowe VJ, McDonald TJ, Rahman MU.
    Arthritis Rheum; 2005 Jun 15; 53(3):337-42. PubMed ID: 15934127
    [Abstract] [Full Text] [Related]

  • 12. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
    Lange G, Maurer J, Mann W.
    Laryngoscope; 2004 Jan 15; 114(1):102-5. PubMed ID: 14710003
    [Abstract] [Full Text] [Related]

  • 13. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar 15; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 14. Transtympanic steroids for Ménière's disease.
    Herraiz C, Plaza G, Aparicio JM, Gallego I, Marcos S, Ruiz C.
    Otol Neurotol; 2010 Jan 15; 31(1):162-7. PubMed ID: 19924013
    [Abstract] [Full Text] [Related]

  • 15. Benign paroxysmal positional vertigo in patients with Ménière's disease treated with intratympanic gentamycin.
    Perez N, Martin E, Zubieta JL, Romero MD, Garcia-Tapia R.
    Laryngoscope; 2002 Jun 15; 112(6):1104-9. PubMed ID: 12160282
    [Abstract] [Full Text] [Related]

  • 16. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial.
    Silverstein H, Isaacson JE, Olds MJ, Rowan PT, Rosenberg S.
    Am J Otol; 1998 Mar 15; 19(2):196-201. PubMed ID: 9520056
    [Abstract] [Full Text] [Related]

  • 17. Long-term results of gentamicin inner ear perfusion in Ménière's disease.
    Suryanarayanan R, Cook JA.
    J Laryngol Otol; 2004 Jul 15; 118(7):489-95. PubMed ID: 15318953
    [Abstract] [Full Text] [Related]

  • 18. Methotrexate in the management of immune mediated cochleovesitibular disorders: clinical experience with 53 patients.
    Salley LH, Grimm M, Sismanis A, Spencer RF, Wise CM.
    J Rheumatol; 2001 May 15; 28(5):1037-40. PubMed ID: 11361185
    [Abstract] [Full Text] [Related]

  • 19. Validity of the Western blot immunoassay for heat shock protein-70 in associated and isolated immunorelated inner ear disease.
    García Berrocal JR, Ramírez-Camacho R, Arellano B, Vargas JA.
    Laryngoscope; 2002 Feb 15; 112(2):304-9. PubMed ID: 11889388
    [Abstract] [Full Text] [Related]

  • 20. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
    Kasemsuwan L, Jariengprasert C, Ruencharopen S, Orathai P.
    J Med Assoc Thai; 2007 Feb 15; 90(2):327-34. PubMed ID: 17375639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.